PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

207 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
141.
Oak, P. et al.: TGF-beta affects functional properties by altering PDGF signaling in stretched and unstretched neonatal lung (myo)fibroblast. Am. J. Respir. Crit. Care Med. 191:A4079 (2015)
142.
Schamberger, A.C. ; Staab-Weijnitz, C.A. ; Mise, N. & Eickelberg, O.: Cigarette smoke extract shifts human bronchial basal cell differentiation towards a COPD-associated phenotype. Am. J. Respir. Crit. Care Med. 191:A1047 (2015)
143.
Semren, N. et al.: Regulation of 26S proteasome activity in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 192, 1089-1101 (2015)
144.
Staab-Weijnitz, C.A. et al.: FK506-binding protein 10 is a potential novel drug target for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 192, 455-467 (2015)
145.
Staab-Weijnitz, C.A. et al.: The chaperones FKBP10 and FKBP11 are increased in pulmonary fibrosis and affect collagen synthesis and secretion in primary human fibroblasts. Am. J. Respir. Crit. Care Med. 191:A5341 (2015)
146.
Sterclova, M.* et al.: Cigarette smoke may contribute to IPF pathogenesis by effect on Wnt-1, Wnt-3 and Mmp-7 production by cells present in alveoli of IPF patients. Am. J. Respir. Crit. Care Med. 191:A2052 (2015)
147.
Thannickal, V.J.* et al.: Blue journal conference : Aging and susceptibility to lung disease. Am. J. Respir. Crit. Care Med. 191, 261-269 (2015)
148.
Vierkotten, S. ; Mutze, K. ; Uhl, F. & Königshoff, M.: Heparan sulfate proteoglycan alterations mediate Wnt/beta-catenin signaling in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 191:A5338 (2015)
149.
Wacker, M. et al.: Work absenteeism and healthcare utilization in COPD: The clinical cohort COSYCONET compared with population-based controls. Am. J. Respir. Crit. Care Med. 191:A2310 (2015)
150.
Watz, H.* et al.: Prevalence of peripheral artery disease in patients with chronic obstructive pulmonary disease: Results of the COSYCONET study. Am. J. Respir. Crit. Care Med. 191:A5710 (2015)
151.
Welk, V. et al.: Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasome activator 200. Am. J. Respir. Crit. Care Med. 191:A4935 (2015)
152.
Wilke, S.* et al.: Impact of peripheral artery disease on functional capacity and health status in patients with chronic obstructive pulmonary disease: Results of the COSYCONET study. Am. J. Respir. Crit. Care Med. 191:A6204 (2015)
153.
Denholm, R.* et al.: Is previous respiratory disease a risk factor for lung cancer? Am. J. Respir. Crit. Care Med. 190, 549-559 (2014)
154.
Dimakopoulou, K.* et al.: Air pollution and nonmalignant respiratory mortality in 16 cohorts within the ESCAPE project. Am. J. Respir. Crit. Care Med. 189, 684-696 (2014)
155.
Herold, S.* & Staab-Weijnitz, C.A.: Glutathione on the Fas track. A novel drug target for the treatment of pseudomonas infection? Am. J. Respir. Crit. Care Med. 189, 386-389 (2014)
156.
Jenne, D.: Off-target rewards of augmentation therapy with α1-antitrypsin. Am. J. Respir. Crit. Care Med. 190, 1203-1204 (2014)
157.
Königshoff, M.: Live and let die: Targeting alveolar epithelial cell proliferation in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 190, 1339-1341 (2014)
158.
Boudier, A.* et al.: Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts. Am. J. Respir. Crit. Care Med. 188, 550-560 (2013)
159.
Gottardi, C.J.* & Königshoff, M.: Considerations for targeting β-catenin signaling in fibrosis. Am. J. Respir. Crit. Care Med. 187, 566-568 (2013)
160.
Griese, M.* et al.: Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. Am. J. Respir. Crit. Care Med. 188, 83-89 (2013)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮